Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - GLOBUS MEDICAL INC | gmed123117ex312.htm |
| EX-31.1 - EXHIBIT 31.1 - GLOBUS MEDICAL INC | gmed123117ex311.htm |
| EX-23.2 - EXHIBIT 23.2 - GLOBUS MEDICAL INC | gmed123117ex232gtconsent.htm |
| EX-23.1 - EXHIBIT 23.1 - GLOBUS MEDICAL INC | gmed123117ex231dtconsent.htm |
| EX-21.1 - EXHIBIT 21.1 - GLOBUS MEDICAL INC | gmed123117ex211entities.htm |
| EX-10.17 - EXHIBIT 10.17 - GLOBUS MEDICAL INC | gmed123117ex1017eischwartz.htm |
| 10-K - 10-K - GLOBUS MEDICAL INC | gmed12311710k.htm |
EXHIBIT 32
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted
Pursuant to Section 906 of The Sarbanes-Oxley Act of 2002
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 1350 of Chapter 63 of Title 18 of the United States Code), David M. Demski, Chief Executive Officer, and Daniel T. Scavilla, Senior Vice President and Chief Financial Officer of Globus Medical, Inc. (the “Company”), each certifies with respect to the Annual Report of the Company on Form 10-K for the period ended December 31, 2017 (the “Report”) that, to the best of his knowledge:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: | February 22, 2018 | /s/ DAVID M. DEMSKI |
David M. Demski | ||
Chief Executive Officer | ||
Dated: | February 22, 2018 | /s/ DANIEL T. SCAVILLA |
Daniel T. Scavilla | ||
Senior Vice President | ||
Chief Financial Officer | ||
The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 1350 of Chapter 63 of Title 18 of the United States Code) and is not being filed as part of the Report or as a separate disclosure document.